Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Vita Life Sciences Limited ( (AU:VLS) ).
Vita Life Sciences Limited has continued its on-market share buy-back program, reporting that a total of 572,459 ordinary fully paid shares had been repurchased prior to the latest trading day. The company disclosed that a further 14,000 shares were bought back on the previous day, as part of its ongoing daily buy-back activity first notified in May 2025.
The update signals the company’s sustained commitment to using buy-backs as a capital management tool, which can support earnings per share and potentially underpin the share price. Regular daily notifications also provide transparency for investors, helping stakeholders track the scale and pace of the program and gauge management’s view of the company’s valuation.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$3.00 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited is an ASX-listed company in the life sciences sector, trading under the code VLS with ordinary fully paid shares. The business operates in the broader healthcare and biotechnology investment space, where capital management initiatives such as share buy-backs are commonly used to optimise capital structure and support shareholder value.
Average Trading Volume: 10,674
Technical Sentiment Signal: Buy
Current Market Cap: A$134.4M
For a thorough assessment of VLS stock, go to TipRanks’ Stock Analysis page.